Archer-Daniels-Midland Faces Revenue and EPS Declines, Analysts Pass on Stock

Earnings
โดย Yahoo Finance·Read original
Summary · why it matters

Archer-Daniels-Midland's stock has returned 28% over the past six months, outpacing the S&P 500 by 20.1% and reaching $86.22 per share, but analysts are passing on the stock for now. The company's revenue declined at a 7.5% annual rate over the last three years, while its gross margin averaged just 6.3% over the past two years, indicating weak pricing power and competitive pressures. Earnings per share fell even more sharply, dropping 24.7% annually over the same three-year period, as fixed costs amplified the impact of shrinking demand. With shares trading at 16 times forward earnings, the valuation is seen as fair but offering limited upside relative to potential downside, leading to a preference for other investment opportunities.

Impact on stocks 1

Synthetic Biology (non-pharma) · 1 stocks